A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon Journal Article


Authors: Welborn, M. B. 3rd; Van Zee, K.; Edwards, P. D.; Pruitt, J. H.; Kaibara, A.; Vauthey, J. N.; Rogy, M.; Castleman, W. L.; Lowry, S. F.; Kenney, J. S.; Stüber, D.; Ettlin, U.; Wipf, B.; Loetscher, H.; Copeland, E. M. 3rd; Lesslauer, W.; Moldawer, L. L.
Article Title: A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon
Abstract: Tumor necrosis factor (TNF) is a potentially useful adjunct to anticancer therapies. However, the clinical utility of TNF has been limited by generalized toxicity and hypotension. Recently, studies have begun to dissect the individual proinflammatory and immunologic responses that result from TNF binding to its two cellular receptors, p55 and p75, in an attempt to develop TNF receptor agonists with reduced systemic toxicity. To evaluate a p75 receptor selective TNF mutant (p75TNF), TNF and p75TNF were administered to healthy anesthetized baboons. Intravenous infusion of the p75TNF produced none of the hemodynamic changes seen after the infusion of TNF. Infusion of p75TNF also failed to induce the plasma appearance of interleukins 6 and 8. However, p75TNF enhanced in vitro baboon thymocyte proliferation to concanavalin A, and infusion of p75TNF resulted in increased soluble p55 and p75 receptor plasma concentrations. Local skin necrosis and tissue neutrophil infiltration were seen after subcutaneous rejections of TNF and p55TNF. Subcutaneous injection of p75TNF did not result in skin necrosis but did result in a modest dermal infiltration of lymphocytes and macrophages. The findings suggest that p75TNF may stimulate T cell proliferation without the systemic and local toxicity seen with TNF.
Keywords: controlled study; unclassified drug; nonhuman; cell proliferation; t-lymphocytes; animal cell; animals; animal tissue; interleukin 8; animal model; inflammation; hypotension; lymphocyte activation; cytokines; species specificity; tumor necrosis factor-alpha; recombinant tumor necrosis factor; shock; interleukin 6; toxicity testing; immunomodulation; antigens, cd; t lymphocyte activation; skin necrosis; neutrophil chemotaxis; receptor binding; intravenous drug administration; receptors, tumor necrosis factor; protein p75; binding, competitive; shock, septic; protein p55; concanavalin a; hemodynamic processes; humans; priority journal; article; tumor necrosis factor p 75; tumor necrosis factor receptor agonist; baboon; body temperature regulation; papio; receptors, tumor necrosis factor, type ii
Journal Title: Journal of Experimental Medicine
Volume: 184
Issue: 1
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 1996-07-01
Start Page: 165
End Page: 171
Language: English
DOI: 10.1084/jem.184.1.165
PUBMED: 8691130
PROVIDER: scopus
PMCID: PMC2192685
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kimberly J Van Zee
    293 Van Zee